Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.
Identifieur interne : 002310 ( PubMed/Corpus ); précédent : 002309; suivant : 002311Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.
Auteurs : Woan-Eng Chan ; Chin-Kai Chuang ; Shiou-Hwei Yeh ; Mau-Sun Chang ; Steve S-L ChenSource :
- Journal of virology [ 0022-538X ] ; 2006.
English descriptors
- KwdEn :
- Amino Acid Substitution, Animals, Biotinylation, Cell Line, Chloramphenicol O-Acetyltransferase (metabolism), Chlorocebus aethiops, Humans, Luciferases (metabolism), Membrane Fusion, Models, Molecular, Molecular Weight, Precipitin Tests, Proline (metabolism), Protein Structure, Secondary, Protein Structure, Tertiary, Repetitive Sequences, Amino Acid (genetics), SARS Virus (chemistry), SARS Virus (genetics), SARS Virus (metabolism), Vero Cells, Viral Fusion Proteins (metabolism).
- MESH :
- chemical , metabolism : Chloramphenicol O-Acetyltransferase, Luciferases, Proline, Viral Fusion Proteins.
- chemistry : SARS Virus.
- genetics : Repetitive Sequences, Amino Acid, SARS Virus.
- metabolism : SARS Virus.
- Amino Acid Substitution, Animals, Biotinylation, Cell Line, Chlorocebus aethiops, Humans, Membrane Fusion, Models, Molecular, Molecular Weight, Precipitin Tests, Protein Structure, Secondary, Protein Structure, Tertiary, Vero Cells.
Abstract
To understand the roles of heptad repeat 1(HR1) and HR2 of the spike (S) protein of the severe acute respiratory syndrome coronavirus (SARS-CoV) in virus-cell interactions, the conserved Leu or Ile residues located at positions 913, 927, 941, and 955 in HR1 and 1151, 1165, and 1179 in HR2 were individually replaced with an alpha-helix-breaker Pro residue. The 913P mutant was expressed mainly as a faster-migrating, lower-molecular-weight S(L) form, while the wild type and all other mutants produced similar levels of both the S(L) form and the slower-migrating, higher-molecular-weight S(H) form. The wild-type S(L) form was processed to the S(H) form, whereas the S(L) form of the 913P mutant was inefficiently converted to the S(H) form after biosynthesis. None of these mutations affected cell surface expression or binding to its cognate ACE2 receptor. In a human immunodeficiency virus type 1/SARS S coexpression study, all mutants except the 913P mutant incorporated the S(H) form into the virions as effectively as did the wild-type S(H) form. The mutation at Ile-1151 did not affect membrane fusion or viral entry. The impaired viral entry of the 927P, 941P, 955P, and 1165P mutants was due to their inability to mediate membrane fusion, whereas the defect in viral entry of the 1179P mutant occurred not at the stage of membrane fusion but rather at a postfusion stage. Our study demonstrates the functional importance of HR1 and HR2 of the SARS-CoV spike protein in membrane fusion and viral entry.
DOI: 10.1128/JVI.80.7.3225-3237.2006
PubMed: 16537590
Links to Exploration step
pubmed:16537590Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.</title>
<author><name sortKey="Chan, Woan Eng" sort="Chan, Woan Eng" uniqKey="Chan W" first="Woan-Eng" last="Chan">Woan-Eng Chan</name>
<affiliation><nlm:affiliation>Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei 11529, Taiwan, Republic of China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chuang, Chin Kai" sort="Chuang, Chin Kai" uniqKey="Chuang C" first="Chin-Kai" last="Chuang">Chin-Kai Chuang</name>
</author>
<author><name sortKey="Yeh, Shiou Hwei" sort="Yeh, Shiou Hwei" uniqKey="Yeh S" first="Shiou-Hwei" last="Yeh">Shiou-Hwei Yeh</name>
</author>
<author><name sortKey="Chang, Mau Sun" sort="Chang, Mau Sun" uniqKey="Chang M" first="Mau-Sun" last="Chang">Mau-Sun Chang</name>
</author>
<author><name sortKey="Chen, Steve S L" sort="Chen, Steve S L" uniqKey="Chen S" first="Steve S-L" last="Chen">Steve S-L Chen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16537590</idno>
<idno type="pmid">16537590</idno>
<idno type="doi">10.1128/JVI.80.7.3225-3237.2006</idno>
<idno type="wicri:Area/PubMed/Corpus">002310</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002310</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.</title>
<author><name sortKey="Chan, Woan Eng" sort="Chan, Woan Eng" uniqKey="Chan W" first="Woan-Eng" last="Chan">Woan-Eng Chan</name>
<affiliation><nlm:affiliation>Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei 11529, Taiwan, Republic of China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chuang, Chin Kai" sort="Chuang, Chin Kai" uniqKey="Chuang C" first="Chin-Kai" last="Chuang">Chin-Kai Chuang</name>
</author>
<author><name sortKey="Yeh, Shiou Hwei" sort="Yeh, Shiou Hwei" uniqKey="Yeh S" first="Shiou-Hwei" last="Yeh">Shiou-Hwei Yeh</name>
</author>
<author><name sortKey="Chang, Mau Sun" sort="Chang, Mau Sun" uniqKey="Chang M" first="Mau-Sun" last="Chang">Mau-Sun Chang</name>
</author>
<author><name sortKey="Chen, Steve S L" sort="Chen, Steve S L" uniqKey="Chen S" first="Steve S-L" last="Chen">Steve S-L Chen</name>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Substitution</term>
<term>Animals</term>
<term>Biotinylation</term>
<term>Cell Line</term>
<term>Chloramphenicol O-Acetyltransferase (metabolism)</term>
<term>Chlorocebus aethiops</term>
<term>Humans</term>
<term>Luciferases (metabolism)</term>
<term>Membrane Fusion</term>
<term>Models, Molecular</term>
<term>Molecular Weight</term>
<term>Precipitin Tests</term>
<term>Proline (metabolism)</term>
<term>Protein Structure, Secondary</term>
<term>Protein Structure, Tertiary</term>
<term>Repetitive Sequences, Amino Acid (genetics)</term>
<term>SARS Virus (chemistry)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (metabolism)</term>
<term>Vero Cells</term>
<term>Viral Fusion Proteins (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Chloramphenicol O-Acetyltransferase</term>
<term>Luciferases</term>
<term>Proline</term>
<term>Viral Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Repetitive Sequences, Amino Acid</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Substitution</term>
<term>Animals</term>
<term>Biotinylation</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Humans</term>
<term>Membrane Fusion</term>
<term>Models, Molecular</term>
<term>Molecular Weight</term>
<term>Precipitin Tests</term>
<term>Protein Structure, Secondary</term>
<term>Protein Structure, Tertiary</term>
<term>Vero Cells</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To understand the roles of heptad repeat 1(HR1) and HR2 of the spike (S) protein of the severe acute respiratory syndrome coronavirus (SARS-CoV) in virus-cell interactions, the conserved Leu or Ile residues located at positions 913, 927, 941, and 955 in HR1 and 1151, 1165, and 1179 in HR2 were individually replaced with an alpha-helix-breaker Pro residue. The 913P mutant was expressed mainly as a faster-migrating, lower-molecular-weight S(L) form, while the wild type and all other mutants produced similar levels of both the S(L) form and the slower-migrating, higher-molecular-weight S(H) form. The wild-type S(L) form was processed to the S(H) form, whereas the S(L) form of the 913P mutant was inefficiently converted to the S(H) form after biosynthesis. None of these mutations affected cell surface expression or binding to its cognate ACE2 receptor. In a human immunodeficiency virus type 1/SARS S coexpression study, all mutants except the 913P mutant incorporated the S(H) form into the virions as effectively as did the wild-type S(H) form. The mutation at Ile-1151 did not affect membrane fusion or viral entry. The impaired viral entry of the 927P, 941P, 955P, and 1165P mutants was due to their inability to mediate membrane fusion, whereas the defect in viral entry of the 1179P mutant occurred not at the stage of membrane fusion but rather at a postfusion stage. Our study demonstrates the functional importance of HR1 and HR2 of the SARS-CoV spike protein in membrane fusion and viral entry.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16537590</PMID>
<DateCompleted><Year>2006</Year>
<Month>04</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>80</Volume>
<Issue>7</Issue>
<PubDate><Year>2006</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.</ArticleTitle>
<Pagination><MedlinePgn>3225-37</MedlinePgn>
</Pagination>
<Abstract><AbstractText>To understand the roles of heptad repeat 1(HR1) and HR2 of the spike (S) protein of the severe acute respiratory syndrome coronavirus (SARS-CoV) in virus-cell interactions, the conserved Leu or Ile residues located at positions 913, 927, 941, and 955 in HR1 and 1151, 1165, and 1179 in HR2 were individually replaced with an alpha-helix-breaker Pro residue. The 913P mutant was expressed mainly as a faster-migrating, lower-molecular-weight S(L) form, while the wild type and all other mutants produced similar levels of both the S(L) form and the slower-migrating, higher-molecular-weight S(H) form. The wild-type S(L) form was processed to the S(H) form, whereas the S(L) form of the 913P mutant was inefficiently converted to the S(H) form after biosynthesis. None of these mutations affected cell surface expression or binding to its cognate ACE2 receptor. In a human immunodeficiency virus type 1/SARS S coexpression study, all mutants except the 913P mutant incorporated the S(H) form into the virions as effectively as did the wild-type S(H) form. The mutation at Ile-1151 did not affect membrane fusion or viral entry. The impaired viral entry of the 927P, 941P, 955P, and 1165P mutants was due to their inability to mediate membrane fusion, whereas the defect in viral entry of the 1179P mutant occurred not at the stage of membrane fusion but rather at a postfusion stage. Our study demonstrates the functional importance of HR1 and HR2 of the SARS-CoV spike protein in membrane fusion and viral entry.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chan</LastName>
<ForeName>Woan-Eng</ForeName>
<Initials>WE</Initials>
<AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei 11529, Taiwan, Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chuang</LastName>
<ForeName>Chin-Kai</ForeName>
<Initials>CK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Yeh</LastName>
<ForeName>Shiou-Hwei</ForeName>
<Initials>SH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chang</LastName>
<ForeName>Mau-Sun</ForeName>
<Initials>MS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Steve S-L</ForeName>
<Initials>SS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014760">Viral Fusion Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9DLQ4CIU6V</RegistryNumber>
<NameOfSubstance UI="D011392">Proline</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.13.12.-</RegistryNumber>
<NameOfSubstance UI="D008156">Luciferases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.3.1.28</RegistryNumber>
<NameOfSubstance UI="D015500">Chloramphenicol O-Acetyltransferase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="Y">Amino Acid Substitution</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019921" MajorTopicYN="N">Biotinylation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015500" MajorTopicYN="N">Chloramphenicol O-Acetyltransferase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008561" MajorTopicYN="N">Membrane Fusion</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011233" MajorTopicYN="N">Precipitin Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011392" MajorTopicYN="N">Proline</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017433" MajorTopicYN="N">Protein Structure, Secondary</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020449" MajorTopicYN="Y">Repetitive Sequences, Amino Acid</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014760" MajorTopicYN="N">Viral Fusion Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>4</Month>
<Day>14</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16537590</ArticleId>
<ArticleId IdType="pii">80/7/3225</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.80.7.3225-3237.2006</ArticleId>
<ArticleId IdType="pmc">PMC1440416</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Biol Chem. 2004 Nov 19;279(47):49414-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15345712</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2005 Oct 10;341(1):122-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16081124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2005 May 10;335(2):276-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15840526</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Jul;79(13):8374-87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15956582</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2000 Apr;74(8):3548-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10729129</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Biochem. 2000;69:531-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10966468</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Biophys Biomol Struct. 2001;30:87-104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11340053</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Biochem. 2001;70:777-810</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11395423</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2002 May 3;277(18):15363-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11859090</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2003 Aug;77(16):8801-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12885899</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14651994</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14670965</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Feb 20;314(4):931-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14751221</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14983044</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15010527</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2004 Mar 20;363(9413):938-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15043961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 May;78(9):4552-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15078936</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 May;78(10):5157-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15113898</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6641-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15096611</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 May 14;279(20):20836-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14996844</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Jun;78(11):5642-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15140961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Jun 18;319(1):283-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15158473</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Jun;78(12):6134-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15163706</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2004 Jul;73(3):338-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15170626</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15150417</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Jul 2;319(3):746-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15184046</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8709-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15161975</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Jul 16;279(29):30514-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15123674</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nutr Rev. 2004 Jun;62(6 Pt 1):243-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15291397</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Sep;78(17):9007-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15308697</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Oct;78(19):10328-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15367599</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Oct;78(19):10628-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15367630</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Oct;78(20):11429-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15452268</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1994 Sep 1;371(6492):37-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8072525</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1995 Feb 1;206(2):935-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7531918</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Biol. 1995 Oct;131(2):339-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7593163</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 1995 Nov 21;34(46):14955-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7578108</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Struct Biol. 1995 Dec;2(12):1075-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8846219</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 1996 Apr 1;15(7):1507-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8612573</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 1996 Apr 15;15(8):2020-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8617249</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1996 Dec 15;226(2):260-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8955046</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Cell Dev Biol. 1996;12:627-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8970739</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1997 Apr 18;89(2):263-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9108481</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1997 May 22;387(6631):426-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9163431</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6065-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9177169</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12303-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9356444</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1998 Jun;72(6):4765-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9573241</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 1998 Aug 17;17(16):4572-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9707417</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2005 Aug;86(Pt 8):2269-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16033974</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Nov;78(21):12090-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15479853</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1981 Jan 29;289(5796):366-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7464906</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1990 May;64(5):2416-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2325207</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1993 May 21;73(4):823-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8500173</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbiol Mol Biol Rev. 1998 Dec;62(4):1171-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9841669</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1999 Mar;73(3):2469-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9971832</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2004 Nov 9;43(44):14064-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15518555</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):17958-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15604146</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002310 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002310 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:16537590 |texte= Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:16537590" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |